This information is intended for Healthcare Professionals
You will now be re-directed to www.pfizermedicalinformation.com
Mevrometostat (PF-06821497) is an investigational compound. Its safety and efficacy have not been established.
Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)
Phase 1
NCT03460977
Castration Resistant Prostate Cancer (CRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)
Metastatic Castration-Resistant Prostate Cancer
Phase 3
NCT06629779
Back
